Catalent Pharma Solutions 1Q Revenues: $438 million (+10%) 1Q Loss: $11.3 million ($1.1 million in 1Q06 earnings) Comments: Oral Technologies net revenue grew 9% to $235 million, while Sterile Technologies was up 26% to $71 million, fueled by higher utilization and throughput, along with new facilities in Brussels and North Carolina. The weakened U.S. dollar accounted for approximately 5% of sales growth....